Thabor Therapeutics
Paris
About Thabor Therapeutics
Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases. They concentrated on inhibiting a new target to treat human mucosal inflammatory disorders. They also enable healthcare providers to cure their patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Jul 2022)
- Website: thabor-tx.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/thabor-therapeutics-35146 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.